Industry News

DexCom Opens Data Platform and Launches Developer Program to Fuel Diabetes App Innovation

You are here

Tuesday, September 19, 2017

CGM Leader Introduces Public Application Programming Interface (API)

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM), the leader in continuous glucose monitoring (CGM), announced today the availability of a public API, empowering third-party developers to connect patient-authorized CGM data into a broad range of software applications. This pioneering approach to CGM data sharing is intended to enable a rich ecosystem of novel solutions and put the user in control of where and how they interact with their glucose data.

"In launching this developer platform, Dexcom combines our CGM data expertise with the creativity of the developer ecosystem to enable new solutions and business models in the treatment and management of diabetes," said Annika Jimenez, Senior Vice President of Data, Dexcom. "Dexcom believes in data mobility and customer choice. It also believes that the API opens up opportunities to drive Dexcom CGM data into the heart of new digital solutions for payers, providers, and most importantly people with diabetes."

Continuous glucose monitoring allows people with diabetes to continuously track their blood glucose levels in real-time. Dexcom CGM systems provide dynamic glucose information every five minutes, which creates a continuous stream of glucose data that can be invaluable for individual and population diabetes management. The Dexcom API allows Dexcom to ensure CGM data collaboration is secure, patient-privacy-centric, and FDA-compliant, while supporting a broad variety of new solutions and business models.

"Diabetes is a data-driven disease," said Jeff Dachis, Founder and Chief Executive Officer of One Drop, a leading digital diabetes management solution and Dexcom API user. "By combining Dexcom data with One Drop's ability to connect users, coaches and diabetes peers, this partnership will help drive innovation and will bring about more affordable, accessible, scalable, and effective solutions. It's a big win for people with diabetes."

As of today, developers in the US can register at https://developer.dexcom.com and immediately access the Dexcom API. Several well-established companies and startups in the diabetes space including One Drop, Nutrino, Tidepool, Rimidi, Evidation, Ensa, and App Practice are already accessing the API for patient-approved CGM data retrieval.

"AppPractice's new platform allows clinicians to view their patient's glucose on the same day via their smartphones, as part of their mHealth patient care practice," said Dr. Rakesh Patel, Endocrinologist, entrepreneur and founder of App Practice. "By using the data from the Dexcom API, our clinicians can now make timely changes and adjust insulin for their patients more effectively. Access to patient data like this enables clinicians to dramatically improve patient care and can lower healthcare costs."

Dexcom customers will benefit from the apps these companies have developed in many ways; for example:

Clinicians can now view their diabetes patients' glucose data on their smartphones, as part of their mobile practice patient care and billing workflows.
Patients are able to receive automated, personalized insights gained from combining data from their diabetes devices, medical records, and other apps and wearables.
Dexcom users can explore how their food choices impact their glucose control and connect with and learn from coaches and diabetes peers in a data-driven community.

"Dexcom has always been a pioneer in diabetes technology," said Kevin Sayer, President and CEO, Dexcom. "Now we are extending our thought leadership into the data our device generates by enabling broad collaboration with digital health partners."

About DexCom, Inc.

DexCom, Inc., headquartered in San Diego, CA, is dedicated to helping people better manage their diabetes by developing and marketing continuous glucose monitoring (CGM) products and tools for adult and pediatric patients. With exceptional performance, patient comfort and lifestyle flexibility at the heart of its technology, users have consistently ranked DexCom highest in customer satisfaction and loyalty. For more information, visit www.dexcom.com.

View source version on businesswire.comhttp://www.businesswire.com/news/home/20170919005708/en/

DexCom, Inc.
Media Contact
James McIntosh, 619-884-2118
jmcintosh@allisonpr.com
or
Investor Contact
Steven Pacelli, 858-200-0200
spacelli@dexcom.com

Source: DexCom, Inc.

News Provided by Acquire Media

Request Dexcom Information for Your Practice

If you are a clinician and want to learn more about Dexcom’s Continuous Glucose Monitoring Systems, please fill out the form and a Dexcom representative will contact you.

If you are a Dexcom User or Patient, please contact Dexcom here.

The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.